Published: 2016-08-01
Review
The Association between ANXA11 Gene Polymorphisms and Sarcoidosis: a Meta-Analysis and systematic review
Abstract 282 | PDF Downloads 83Page 102-111
An epidemiological perspective of the pathology and etiology of sarcoidosis
Abstract 1467 | PDF Downloads 301Page 112-116
Original Articles: Clinical Research
High-resolution CT predictors of hypersensitivity pneumonitis
Abstract 437 | PDF Downloads 476Page 117-123
Fatigue and health-related quality of life in patients with pulmonary sarcoidosis treated by oral Corticosteroids
Abstract 347 | PDF Downloads 552Page 124-129
Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases
Abstract 301 | PDF Downloads 337Page 130-138
Serum fibroblastic growth factor 23 in acute Sarcoidosis and normal kidney function
Abstract 215 | PDF Downloads 128Page 139-142
Platelet aggregability in patients with interstitial pneumonias
Abstract 213 | PDF Downloads 177Page 143-150
Evaluation of Tpeak-Tend interval and Tpeak-end/QT ratio in patients with Sarcoidosis
Abstract 348 | PDF Downloads 224Page 151-156
Exercise related ventilation dynamics and clinical correlates in patients with fibrotic idiopathic interstitial pneumonias
Abstract 310 | PDF Downloads 149Page 157-165
Case Reports
Polishing surgical metal pieces, granulomatosis and mineralogical analysis
Abstract 236 | PDF Downloads 118Page 166-170
Pulmonary metastases from low grade sarcoma in a patient with pulmonary sarcoidosis. Sarcoidosis or sarcoid-like reaction?
Abstract 261 | PDF Downloads 204Page 171-174
Cardiac sarcoidosis – silent destroyer.
Abstract 242 | PDF Downloads 157Page 175-177
Sarcoidosis during etanercept treatment for rheumatoid arthritis in women with a history of bilateral oophorectomy
Abstract 634 | PDF Downloads 122Page 178-181
Extensive pulmonary sarcoid reaction in a patient with BMPR-2 associated idiopathic pulmonary arterial hypertension
Abstract 216 | PDF Downloads 65Page 182-185
Successful management of acute respiratory failure in an Idiopathic Pulmonary Fibrosis patient using an extracorporeal carbon dioxide removal system
Abstract 275 | PDF Downloads 139Page 186-190
Letter to Editor
Repositioning ‘old’ drugs to treat rare diseases: arguing from the mechanism of action
Abstract 419 | PDF Downloads 127Page 191-194